Filings & corporate actions
- 31 OctresultsResults · Q2 FY27 · consolidated and standalone+6.8%NSE
- 16 OctshareholdingShareholding · 30 Sept 2026+1.6%NSE
- 8 AugresultsResults · Q1 FY27 · consolidated and standalone-9.2%NSE
- 24 JuldividendDividend · ₹1.35 per share+1.0%
- 18 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
- 9 MayresultsResults · Q4 FY26 · consolidated and standalone+9.3%NSE
- 14 AprshareholdingShareholding · 31 Mar 2026+0.9%NSE
- 31 JanresultsResults · Q3 FY26 · consolidated and standalone-8.4%NSE
- 16 JanshareholdingShareholding · 31 Dec 2025-2.1%NSE
Reaction to results · all yearsrose on day 0 in 20 of 42 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 31 Oct 2026 | +6.8% | +7.8% | — | 4.3× |
| Q1 FY27 | 8 Aug 2026 | -9.2% | -5.8% | -8.2% | 4.5× |
| Q4 FY26 | 9 May 2026 | +9.3% | +1.8% | +4.2% | 23.8× |
| Q3 FY26 | 31 Jan 2026 | -8.4% | -3.2% | +1.2% | 1.5× |
| Q2 FY26 | 12 Nov 2025 | +7.0% | +6.1% | -1.6% | 28.9× |
| Q1 FY26 | 2 Aug 2025 | -8.8% | -16.8% | -5.9% | 3.5× |
| Q4 FY25 | 13 May 2025 | -0.8% | +0.1% | +15.2% | 1.9× |
| Q3 FY25 | 8 Feb 2025 | -2.5% | -9.2% | -16.7% | 1.3× |
| Q2 FY25 | 9 Nov 2024 | -15.3% | -22.3% | -19.8% | 6.4× |
| Q1 FY25 | 10 Aug 2024 | -2.5% | +10.7% | +12.4% | 0.6× |
| Q4 FY24 | 11 May 2024 | -2.9% | -4.6% | -8.5% | 1.2× |
| Q3 FY24 | 10 Feb 2024 | +0.8% | +7.0% | -5.8% | 3.6× |
| Q2 FY24 | 7 Nov 2023 | +1.8% | +0.6% | +7.9% | 3.6× |
| Q1 FY24 | 12 Aug 2023 | +1.4% | 0.0% | -5.4% | 1.2× |
| Q4 FY23 | 13 May 2023 | -1.8% | -4.7% | -5.6% | 8.6× |
| Q3 FY23 | 11 Feb 2023 | -2.5% | -2.6% | -8.4% | 1.0× |
| Q2 FY23 | 11 Nov 2022 | -1.7% | -4.1% | +9.5% | 0.6× |
| Q1 FY23 | 6 Aug 2022 | -4.7% | -9.5% | -5.9% | 1.4× |
| Q4 FY22 | 20 May 2022 | -2.4% | +4.3% | -4.0% | 0.8× |
| Q3 FY22 | 5 Feb 2022 | -5.6% | -10.8% | -11.9% | 1.0× |
| Q2 FY22 | 2 Nov 2021 | -0.7% | -3.3% | -9.7% | 0.8× |
| Q1 FY22 | 7 Aug 2021 | +0.1% | -6.8% | -10.5% | 0.7× |
| Q4 FY21 | 30 May 2021 | -6.4% | -9.1% | -10.1% | 1.0× |
| Q3 FY21 | 12 Feb 2021 | +0.7% | +5.8% | -1.8% | 3.8× |
| Q2 FY21 | 13 Nov 2020 | +2.6% | +4.6% | +8.1% | 1.8× |
| Q1 FY21 | 12 Aug 2020 | -0.4% | +12.5% | +10.2% | 1.1× |
| Q4 FY20 | 30 May 2020 | -0.1% | +7.2% | +15.7% | 1.1× |
| Q3 FY20 | 6 Feb 2020 | +0.3% | -5.0% | -21.5% | 1.2× |
| Q2 FY20 | 2 Nov 2019 | +0.8% | -6.0% | -12.8% | 4.2× |
| Q1 FY20 | 8 Aug 2019 | -1.8% | -3.3% | +4.7% | 0.8× |
| Q4 FY19 | 24 May 2019 | +5.3% | +6.6% | -16.9% | 4.0× |
| Q3 FY19 | 19 Feb 2019 | +0.2% | -6.8% | +11.6% | 0.9× |
| Q2 FY19 | 23 Nov 2018 | -0.6% | -2.4% | -4.9% | 0.5× |
| Q1 FY19 | 24 Aug 2018 | +0.1% | +0.4% | -7.0% | 0.4× |
| Q4 FY18 | 26 May 2018 | +0.8% | -2.6% | +0.2% | 10.5× |
| Q3 FY18 | 16 Mar 2018 | +3.9% | -2.5% | +4.9% | 2.0× |
| Q2 FY18 | 20 Nov 2017 | +0.1% | -0.1% | +7.5% | 0.5× |
| Q1 FY17 | 22 Sept 2017 | -3.0% | -3.4% | +1.8% | 1.0× |
| Q1 FY18 | 22 Sept 2017 | -3.0% | -3.4% | +1.8% | 1.0× |
| Q4 FY17 | 20 Jun 2017 | +0.1% | -4.6% | +3.8% | 0.6× |
| Q3 FY17 | 21 Feb 2017 | +3.2% | +5.5% | +27.9% | 3.2× |
| Q2 FY17 | 18 Nov 2016 | +0.9% | +6.5% | +11.6% | 0.4× |
| Average | -0.9% | -1.6% | -1.0% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +12.2% | +10.0% | +10.4% | +7.8% | +9.5% | +8.7% |
| Profit | +11.6% | +11.0% | +15.5% | +3.6% | +3.7% | +5.1% |
Key data
Delivery percentage
Over the last 20 sessions ADVENZYMES settled 56.0% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 54.2%. The latest session ranks higher than 42% of the 2,541 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -1.96% | +2.42% | +12.21% | -4.14% | -24.79% | -11.93% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 171.9 | 203.4 | 189.8 | 214.5 |
| YoY chg | +1.7% | +21.6% | +2.1% | +16.2% |
| Net profit (₹ Cr) | 43.2 | 45.3 | 38.6 | 51.2 |
| YoY chg | +11.1% | +69.3% | -4.6% | +14.4% |
| Net margin | 25.1% | 22.3% | 20.3% | 23.8% |
| EPS | 3.79 | 3.84 | 3.31 | 4.32 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 43.56% · public 56.44%- Promoter
- Public and others
- Promoter
- 43.56%
- Public
- 56.44%
- Promoter change
- +0.32 pp
- Filed
- 16 Oct 2026
- FII
- 26.65%
- DII
- 1.89%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 1.18%
- Insurance
- 0.00%
- FPI
- 14.49%
- Retail ≤ ₹2L
- 17.12%
- HNI > ₹2L
- 1.54%
- NRI
- 3.34%
- Bodies corporate
- 2.11%
- Shareholders
- 67,468
-0.64 pp QoQ
0.00 pp QoQ
-0.15 pp QoQ
+1.64 pp QoQ
+0.08 pp QoQ
+0.06 pp QoQ
+0.72 pp QoQ
+6.1% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| Vasant Rathi | Promoter · Individual | 26.87% | 2.99Cr |
| Orbimed Asia III Mauritius FVCI Limited | Foreign | 12.15% | 1.35Cr |
| Nalanda India Equity Fund Limited | FPI | 8.38% | 93.17L |
| Vasant and Prabha Rathi Generation Trust | Promoter · Other | 6.75% | 75.00L |
| Polunin Emerging Markets Small Cap Fund, LLC | FPI | 2.48% | 27.53L |
| Rasika Vasant Rathi | Promoter · Individual | 2.40% | 26.66L |
| Reshma Namita Rathi | Promoter · Individual | 2.38% | 26.47L |
| Rachana Vasant Rathi | Promoter · Individual | 2.38% | 26.41L |
| Marval Guru Fund | FPI | 1.80% | 20.00L |
| Pradip Bhailal Shah | Individual | 1.67% | 18.57L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹1.35 | ₹1.35 |
| FY2025-26 | 2 | ₹5.20 | ₹5.20 |
| FY2024-25 | 2 | ₹5.10 | ₹5.10 |
| FY2023-24 | 2 | ₹5.00 | ₹5.00 |
| FY2022-23 | 1 | ₹1.00 | ₹1.00 |
| FY2021-22 | 1 | ₹0.90 | ₹0.90 |
| FY2020-21 | 1 | ₹0.60 | ₹0.60 |
| FY2019-20 | 1 | ₹0.60 | ₹0.60 |
| FY2018-19 | 1 | ₹0.50 | ₹0.50 |
| FY2017-18 | 1 | ₹0.40 | ₹0.40 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 24 Jul 2026 | — | ₹1.35 | ₹1.35 |
| 23 Jul 2025 | — | ₹1.20 | ₹1.20 |
| 16 May 2025 | — | ₹4.00 | ₹4.00 |
| 18 Jul 2024 | — | ₹1.10 | ₹1.10 |
| 17 May 2024 | — | ₹4.00 | ₹4.00 |
| 4 Aug 2023 | — | ₹1.00 | ₹1.00 |
| 19 May 2023 | — | ₹4.00 | ₹4.00 |
| 11 Aug 2022 | — | ₹1.00 | ₹1.00 |
| 31 Aug 2021 | — | ₹0.90 | ₹0.90 |
| 9 Jul 2020 | — | ₹0.60 | ₹0.60 |
| 1 Aug 2019 | — | ₹0.60 | ₹0.60 |
| 6 Sept 2018 | — | ₹0.50 | ₹0.50 |
| 4 Sept 2017 | — | ₹0.40 | ₹0.40 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 8 months ago
- Disclosures on record
- 272
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 18 May 2026 | Rahul Shashikant KirkindeEmployee | Sell | 4.0K | ₹15.2L | 379.59 | 9.7K → 5.7K | 0.01%-0.01 pp | 7(2)told 14 May 2026 |
| 13 Mar 2026 | Vasant RathiPromoter | Buy | 18.0K | ₹53.7L | 298.45 | 2.99Cr → 2.99Cr | 26.69%+0.02 pp | 7(2)told 11 Mar 2026 |
| 10 Mar 2026 | Vasant RathiPromoter | Buy | 65.0K | ₹1.9Cr | 293.60 | 2.98Cr → 2.99Cr | 26.67%+0.06 pp | 7(2)told 10 Mar 2026 |
| 10 Mar 2026 | Vasant RathiPromoter | Buy | 55.0K | ₹1.6Cr | 297.67 | 2.97Cr → 2.98Cr | 26.61%+0.05 pp | 7(2)told 9 Mar 2026 |
| 10 Mar 2026 | Vasant RathiPromoter | Buy | 20.0K | ₹59.1L | 295.38 | 2.97Cr → 2.97Cr | 26.57%+0.02 pp | 7(2)told 7 Mar 2026 |
| 9 Feb 2026 | Vasant RathiPromoter | Buy | 20.0K | ₹58.2L | 291.12 | 2.97Cr → 2.97Cr | 26.55%+0.02 pp | 7(2)told 9 Feb 2026 |
| 7 Feb 2026 | Vasant RathiPromoter | Buy | 37.3K | ₹1.1Cr | 288.19 | 2.97Cr → 2.97Cr | 26.53%+0.03 pp | 7(2)told 6 Feb 2026 |
| 6 Feb 2026 | Vasant RathiPromoter | Buy | 11.4K | ₹32.7L | 287.60 | 2.96Cr → 2.97Cr | 26.50%+0.01 pp | 7(2)told 5 Feb 2026 |
| 6 Feb 2026 | Vasant RathiPromoter | Buy | 21.3K | ₹61.1L | 286.18 | 2.96Cr → 2.96Cr | 26.49%+0.02 pp | 7(2)told 5 Feb 2026 |
| 25 Sept 2025 | Leela Kishor RathiRelative | Sell | 3.0K | ₹10.1L | 338.00 | 1.31L → 1.28L | 0.11%-0.00 pp | 7(2)told 25 Sept 2025 |
| 25 Sept 2025 | Leela Kishor RathiRelative | Sell | 14.2K | ₹47.9L | 338.01 | 1.45L → 1.31L | 0.12%-0.01 pp | 7(2)told 25 Sept 2025 |
| 25 Sept 2025 | Leela Kishor RathiRelative | Sell | 2.0K | ₹6.7L | 335.13 | 1.47L → 1.45L | 0.13%-0.00 pp | 7(2)told 23 Sept 2025 |
| 25 Sept 2025 | Leela Kishor RathiRelative | Sell | 11.2K | ₹37.6L | 336.88 | 1.58L → 1.47L | 0.13%-0.01 pp | 7(2)told 23 Sept 2025 |
| 25 Sept 2025 | Leela Kishor RathiRelative | Sell | 314 | ₹1.1L | 340.04 | 1.59L → 1.58L | 0.14%-0.00 pp | 7(2)told 23 Sept 2025 |
| 25 Sept 2025 | Leela Kishor RathiRelative | Sell | 2.4K | ₹8.1L | 339.86 | 1.61L → 1.59L | 0.14%-0.00 pp | 7(2)told 23 Sept 2025 |
| 2 Jul 2025 | Payal Akshay KulkarniPromoter | Sell | 3.3K | ₹10.8L | 328.07 | 5.5K → 2.2K | 0.00%0.00 pp | 7(2)told 30 Jun 2025 |
| 28 Mar 2025 | Vasant RathiPromoter | Buy | 25.0K | ₹70.6L | 282.54 | 3.71Cr → 3.71Cr | 33.18%+0.02 pp | 7(2)told 26 Mar 2025 |
| 25 Mar 2025 | Vasant RathiPromoter | Buy | 1.50L | ₹4.4Cr | 291.05 | 3.69Cr → 3.71Cr | 33.16%+0.13 pp | 7(2)told 24 Mar 2025 |
| 25 Mar 2025 | Atul BiyaniOther | Buy | 3.0K | ₹8.8L | 292.50 | 4.5K → 7.5K | 0.01%+0.00 pp | 7(2)told 24 Mar 2025 |
| 16 Sept 2024 | Subhash ChakorOther | Sell | 2.4K | ₹12.6L | 536.55 | 26.4K → 24.0K | 0.02%-0.00 pp | 7(2)told 14 Sept 2024 |
| 13 Sept 2024 | Madhusudan KabraPromoter | Sell | 1.00L | ₹5.1Cr | 508.96 | 7.16L → 6.16L | 0.55%-0.09 pp | 7(2)told 12 Sept 2024 |
| 24 Jun 2024 | Chandrakumar Laxminarayan RathiPromoter | Sell | 12.5K | ₹49.9L | 398.92 | 12.5K → — | 0.00% | 7(2)told 21 Jun 2024 |
| 24 Jun 2024 | Chandrakumar Laxminarayan RathiPromoter | Sell | 16.5K | ₹63.6L | 385.80 | 29.0K → 12.5K | 0.01%-0.01 pp | 7(2)told 21 Jun 2024 |
| 18 Jun 2024 | Chandrakumar Laxminarayan RathPromoter | Sell | 17.5K | ₹69.4L | 396.50 | 46.5K → 29.0K | 0.03%-0.02 pp | 7(2)told 17 Jun 2024 |
| 14 Jun 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.21L | ₹4.5Cr | 372.20 | 1.21L → — | 0.00% | 7(2)told 14 Jun 2024 |
| 14 Jun 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.13L | ₹4.1Cr | 363.56 | 2.34L → 1.21L | 0.11%-0.10 pp | 7(2)told 13 Jun 2024 |
| 12 Jun 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.22L | ₹4.4Cr | 361.52 | 3.56L → 2.34L | 0.22%-0.11 pp | 7(2)told 12 Jun 2024 |
| 12 Jun 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 77.0K | ₹2.8Cr | 362.08 | 4.33L → 3.56L | 0.32%-0.07 pp | 7(2)told 12 Jun 2024 |
| 11 Jun 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 55.0K | ₹2.0Cr | 363.21 | 4.88L → 4.33L | 0.39%-0.05 pp | 7(2)told 10 Jun 2024 |
| 26 Feb 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 5.7K | ₹23.6L | 415.07 | 4.93L → 4.88L | 0.44%-0.01 pp | 7(2)told 22 Feb 2024 |
| 20 Feb 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 7.8K | ₹32.4L | 415.19 | 5.01L → 4.93L | 0.44%-0.01 pp | 7(2)told 20 Feb 2024 |
| 20 Feb 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 53.0K | ₹2.2Cr | 416.29 | 5.54L → 5.01L | 0.45%-0.05 pp | 7(2)told 19 Feb 2024 |
| 16 Feb 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 42.6K | ₹1.8Cr | 416.69 | 5.97L → 5.54L | 0.50%-0.04 pp | 7(2)told 16 Feb 2024 |
| 16 Feb 2024 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 30.2K | ₹1.3Cr | 415.58 | 6.27L → 5.97L | 0.53%-0.03 pp | 7(2)told 15 Feb 2024 |
| 2 Jan 2024 | Pramod KasatDirector | Buy | 5.0K | ₹18.8L | 375.03 | — → 5.0K | 0.00% | 7(2)told 30 Dec 2023 |
| 21 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.04L | ₹3.9Cr | 375.16 | 7.31L → 6.27L | 0.56%-0.09 pp | 7(2)told 20 Dec 2023 |
| 19 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 2.92L | ₹10.9Cr | 375.18 | 10.22L → 7.31L | 0.65%-0.26 pp | 7(2)told 19 Dec 2023 |
| 19 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 43.5K | ₹1.6Cr | 375.00 | 10.66L → 10.22L | 0.91%-0.04 pp | 7(2)told 18 Dec 2023 |
| 15 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 3.34L | ₹12.4Cr | 370.91 | 14.00L → 10.66L | 0.95%-0.30 pp | 7(2)told 15 Dec 2023 |
| 14 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.95L | ₹7.1Cr | 366.30 | 15.95L → 14.00L | 1.25%-0.17 pp | 7(2)told 14 Dec 2023 |
| 14 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 79.0K | ₹2.9Cr | 366.80 | 16.74L → 15.95L | 1.43%-0.07 pp | 7(2)told 13 Dec 2023 |
| 12 Dec 2023 | Subhash Damu ChakorOther | Sell | 800 | ₹2.9L | 367.05 | 27.6K → 26.8K | 0.02%-0.00 pp | 7(2)told 11 Dec 2023 |
| 12 Dec 2023 | Subhash Damu ChakorOther | Sell | 200 | ₹70,780 | 353.90 | 27.8K → 27.6K | 0.02%-0.00 pp | 7(2)told 9 Dec 2023 |
| 12 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 3.60L | ₹13.1Cr | 365.12 | 20.33L → 16.74L | 1.50%-0.32 pp | 7(2)told 12 Dec 2023 |
| 8 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 33.1K | ₹1.2Cr | 363.10 | 20.66L → 20.33L | 1.82%-0.03 pp | 7(2)told 8 Dec 2023 |
| 8 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 6.18L | ₹22.2Cr | 359.25 | 26.84L → 20.66L | 1.85%-0.55 pp | 7(2)told 7 Dec 2023 |
| 6 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.07L | ₹3.5Cr | 332.34 | 27.91L → 26.84L | 2.40%-0.10 pp | 7(2)told 6 Dec 2023 |
| 6 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 2.4K | ₹8.1L | 330.59 | 27.93L → 27.91L | 2.50%-0.00 pp | 7(2)told 5 Dec 2023 |
| 2 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 18.1K | ₹60.2L | 331.97 | 28.12L → 27.93L | 2.50%-0.02 pp | 7(2)told 2 Dec 2023 |
| 2 Dec 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 43.7K | ₹1.4Cr | 330.21 | 28.55L → 28.12L | 2.51%-0.04 pp | 7(2)told 1 Dec 2023 |
| 30 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 6.8K | ₹22.4L | 330.23 | 28.62L → 28.55L | 2.55%-0.01 pp | 7(2)told 30 Nov 2023 |
| 30 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.14L | ₹3.8Cr | 338.83 | 29.76L → 28.62L | 2.56%-0.10 pp | 7(2)told 29 Nov 2023 |
| 28 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 16.9K | ₹56.3L | 333.66 | 29.93L → 29.76L | 2.66%-0.02 pp | 7(2)told 27 Nov 2023 |
| 28 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 14.9K | ₹49.6L | 332.45 | 30.07L → 29.93L | 2.68%-0.01 pp | 7(2)told 24 Nov 2023 |
| 23 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.32L | ₹4.4Cr | 334.07 | 31.39L → 30.07L | 2.69%-0.12 pp | 7(2)told 23 Nov 2023 |
| 23 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 18.7K | ₹60.1L | 321.00 | 31.58L → 31.39L | 2.81%-0.02 pp | 7(2)told 22 Nov 2023 |
| 20 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 5.1K | ₹16.4L | 324.02 | 31.63L → 31.58L | 2.82%-0.00 pp | 7(2)told 20 Nov 2023 |
| 20 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 516 | ₹1.7L | 330.09 | 31.64L → 31.63L | 2.83%-0.00 pp | 7(2)told 17 Nov 2023 |
| 16 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 20.4K | ₹67.4L | 330.59 | 31.84L → 31.64L | 8.23%-0.05 pp | 7(2)told 16 Nov 2023 |
| 16 Nov 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 13.6K | ₹44.8L | 330.06 | 31.98L → 31.84L | 2.85%-0.01 pp | 7(2)told 15 Nov 2023 |
| 27 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 4.4K | ₹14.2L | 324.07 | 32.30L → 32.25L | 2.88%-0.00 pp | 7(2)told 25 Sept 2023 |
| 27 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 27.9K | ₹91.0L | 325.88 | 32.55L → 31.98L | 2.86%-0.05 pp | 7(2)told 26 Sept 2023 |
| 22 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 15.8K | ₹51.4L | 324.56 | 32.30L → 32.30L | 2.89%0.00 pp | 7(2)told 22 Sept 2023 |
| 22 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 18.0K | ₹58.6L | 324.84 | 32.64L → 32.46L | 2.90%-0.02 pp | 7(2)told 21 Sept 2023 |
| 15 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 4.3K | ₹14.0L | 324.77 | 32.68L → 32.64L | 2.92%-0.00 pp | 7(2)told 13 Sept 2023 |
| 12 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 46.7K | ₹1.5Cr | 324.34 | 33.94L → 33.47L | 2.99%-0.04 pp | 7(2)told 11 Sept 2023 |
| 12 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 79.0K | ₹2.6Cr | 324.51 | 33.47L → 32.68L | 2.92%-0.07 pp | 7(2)told 12 Sept 2023 |
| 8 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.05L | ₹3.4Cr | 325.52 | 34.99L → 33.94L | 3.03%-0.09 pp | 7(2)told 8 Sept 2023 |
| 8 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 55.2K | ₹1.8Cr | 324.49 | 35.54L → 34.98L | 3.13%-0.05 pp | 7(2)told 7 Sept 2023 |
| 8 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 34.2K | ₹1.1Cr | 324.30 | 35.88L → 35.54L | 3.18%-0.03 pp | 7(2)told 6 Sept 2023 |
| 4 Sept 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 1.6K | ₹5.4L | 330.00 | 35.90L → 35.88L | 3.21%-0.00 pp | 7(2)told 1 Sept 2023 |
| 31 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 10.3K | ₹33.9L | 330.04 | 36.00L → 35.90L | 3.21%-0.01 pp | 7(2)told 31 Aug 2023 |
| 31 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 14.6K | ₹48.2L | 330.18 | 36.15L → 36.00L | 3.22%-0.01 pp | 7(2)told 31 Aug 2023 |
| 31 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 70.1K | ₹2.3Cr | 331.22 | 36.85L → 36.15L | 3.23%-0.06 pp | 7(2)told 29 Aug 2023 |
| 28 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 80.0K | ₹2.6Cr | 330.33 | 37.65L → 36.85L | 3.30%-0.07 pp | 7(2)told 28 Aug 2023 |
| 28 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 47.5K | ₹1.6Cr | 331.48 | 38.12L → 37.65L | 3.37%-0.04 pp | 7(2)told 25 Aug 2023 |
| 28 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 4.5K | ₹15.0L | 330.00 | 38.17L → 38.12L | 3.41%-0.00 pp | 7(2)told 25 Aug 2023 |
| 23 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 7.2K | ₹24.1L | 335.08 | 38.24L → 38.17L | 3.41%-0.01 pp | 7(2)told 22 Aug 2023 |
| 23 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 9.8K | ₹32.4L | 330.00 | 38.34L → 38.24L | 3.42%-0.01 pp | 7(2)told 21 Aug 2023 |
| 18 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 25.3K | ₹84.9L | 335.00 | 38.59L → 38.34L | 3.43%-0.02 pp | 7(2)told 18 Aug 2023 |
| 18 Aug 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 10.2K | ₹34.1L | 335.06 | 38.70L → 38.59L | 3.45%-0.01 pp | 7(2)told 17 Aug 2023 |
| 1 Aug 2023 | Ashish Bharat PujaraRelative | Sell | 18.2K | ₹57.7L | 317.67 | 20.3K → 2.1K | 0.00%0.00 pp | 7(2)told 1 Aug 2023 |
| 1 Aug 2023 | Ashish Bharat PujaraRelative | Sell | 10.0K | ₹31.1L | 310.54 | 30.3K → 20.3K | 0.02%-0.01 pp | 7(2)told 1 Aug 2023 |
| 29 Jun 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 25.51L | ₹68.9Cr | 270.08 | 64.20L → 38.70L | 3.46%-2.28 pp | 7(2)told 28 Jun 2023 |
| 29 Jun 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 37.5K | ₹1.0Cr | 270.67 | 64.58L → 64.20L | 5.74%-0.03 pp | 7(2)told 28 Jun 2023 |
| 29 Jun 2023 | Vasant RathiPromoter | Buy | 431 | ₹1.2L | 271.65 | 3.70Cr → 3.70Cr | 33.13%+0.00 pp | 7(2)told 27 Jun 2023 |
| 29 Jun 2023 | Vasant RathiPromoter | Buy | 6.0K | ₹16.1L | 268.17 | 3.70Cr → 3.70Cr | 33.13%+0.01 pp | 7(2)told 27 Jun 2023 |
| 26 Jun 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 6.6K | ₹17.9L | 270.07 | 64.64L → 64.58L | 5.77%-0.01 pp | 7(2)told 26 Jun 2023 |
| 26 Jun 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 17.3K | ₹46.9L | 271.50 | 64.82L → 64.64L | 5.78%-0.02 pp | 7(2)told 23 Jun 2023 |
| 26 Jun 2023 | Advanced Vital Enzymes Private LimitedPromoter | Sell | 18.3K | ₹50.5L | 275.28 | 65.00L → 64.82L | 5.79%-0.02 pp | 7(2)told 22 Jun 2023 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 29 Aug 2025
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 29 Aug 2025 | Buy · bulk | POLUNIN EMERGING MARKETS SMALL CAP FUND LLC | 12.51L | 353.50 | ₹44.2Cr |
| 29 Aug 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 10.07L | 352.61 | ₹35.5Cr |
| 29 Aug 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 10.07L | 352.13 | ₹35.5Cr |
| 11 Sept 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 8.22L | 507.35 | ₹41.7Cr |
| 11 Sept 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 8.22L | 507.08 | ₹41.7Cr |
| 19 Jun 2024 | Buy · block, also bulk | MOTILAL OSWAL FINANCIAL SERVICES LIMITED | 1.11Cr | 385.00 | ₹425.5Cr |
| 19 Jun 2024 | Sell · block, also bulk | ORBIMED ASIA III MAURITIUS LIMITED | 1.11Cr | 385.00 | ₹425.5Cr |
| 6 Dec 2023 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 7.23L | 358.11 | ₹25.9Cr |
| 6 Dec 2023 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 7.23L | 357.73 | ₹25.9Cr |
| 6 Dec 2023 | Sell · bulk | ADVANCED VITAL ENZYMES PRIVATE LIMITED | 6.18L | 359.25 | ₹22.2Cr |
| 28 Jun 2023 | Sell · bulk | ADVANCED VITAL ENZYMES PRIVATE LIMITED | 25.51L | 270.08 | ₹68.9Cr |
| 28 Jun 2023 | Buy · bulk | ICICI PRUDENTIAL MUTUAL FUND | 10.00L | 270.00 | ₹27.0Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to ADVENZYMES.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 160.9 | 157.8 | 154.5 | 146.1 | 169.1 | 167.2 | 185.9 | 184.5 | 171.9 | 203.4 | 189.8 | 214.5 | |
| Other income | 14.4 | 9.5 | 7.0 | 9.6 | 7.7 | 8.7 | 8.9 | 10.3 | 8.5 | 7.2 | 13.0 | 8.7 | |
| Total income | 175.3 | 167.3 | 161.5 | 155.7 | 176.8 | 175.9 | 194.8 | 194.8 | 180.4 | 210.6 | 202.8 | 223.2 | |
| Total expenses | 116.5 | 112.6 | 112.8 | 113.5 | 123.8 | 132.5 | 139.9 | 135.3 | 133.4 | 150.9 | 149.3 | 154.5 | |
| └ Finance costs | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 1.2 | |
| └ Depreciation | 8.6 | 9.3 | 8.6 | 8.9 | 9.0 | 10.1 | 9.6 | 10.1 | 10.2 | 10.2 | 9.9 | 10.9 | |
| Profit before tax | 58.9 | 39.6 | 48.7 | 42.2 | 53.0 | 43.5 | 54.9 | 59.5 | 58.3 | 59.8 | 53.5 | 68.8 | |
| Tax expense | 16.4 | 9.7 | 13.7 | 8.8 | 14.1 | 16.7 | 14.5 | 14.8 | 15.1 | 14.6 | 14.9 | 17.6 | |
| Net profit | 42.5 | 29.9 | 35.0 | 33.4 | 38.9 | 26.7 | 40.4 | 44.7 | 43.2 | 45.3 | 38.6 | 51.2 | |
| EPS | 3.74 | 2.53 | 3.05 | 2.94 | 3.36 | 2.37 | 3.57 | 3.87 | 3.80 | 3.84 | 3.31 | 4.33 | |
| Net margin | 26.41% | 18.93% | 22.63% | 22.86% | 22.99% | 15.99% | 21.75% | 24.24% | 25.11% | 22.25% | 20.33% | 23.85% | |
| PBT margin | 36.58% | 25.10% | 31.50% | 28.89% | 31.35% | 26.00% | 29.53% | 32.27% | 33.90% | 29.41% | 28.20% | 32.05% | |
| Tax rate | 27.81% | 24.58% | 28.14% | 20.89% | 26.68% | 38.50% | 26.34% | 24.87% | 25.92% | 24.33% | 27.91% | 25.58% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 31 Oct 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,421.8 | 1,443.9 | 1,535.5 | 1,549.2 | 1,621.3 | 1,691.9 | 1,838.8 | 1,905.7 | |
| Current assets | 722.1 | 736.7 | 809.7 | 807.2 | 879.9 | 933.5 | 1,043.6 | 1,042.7 | |
| └ Cash & equivalents | 96.4 | 99.9 | 113.8 | 97.8 | 94.2 | 62.4 | 108.8 | 158.8 | |
| └ Other bank balances | 26.9 | 26.1 | 29.7 | 13.5 | 13.5 | 14.1 | 7.2 | 26.6 | |
| └ Current investments | 359.6 | 341.8 | 402.9 | 395.7 | 480.3 | 529.3 | 583.8 | 487.3 | |
| └ Trade receivables | 100.3 | 112.0 | 98.6 | 98.8 | 115.4 | 125.3 | 145.0 | 138.0 | |
| └ Inventories | 124.0 | 135.6 | 148.5 | 168.4 | 157.3 | 173.4 | 177.3 | 202.7 | |
| Total equity | 1,284.2 | 1,298.7 | 1,371.1 | 1,388.8 | 1,468.7 | 1,533.6 | 1,683.1 | 1,719.9 | |
| └ Attributable to owners | 1,235.1 | 1,248.3 | 1,324.1 | 1,341.7 | 1,420.9 | 1,484.5 | 1,632.0 | 1,664.8 | |
| └ Non-controlling interest | 49.1 | 50.5 | 47.0 | 47.1 | 47.8 | 49.0 | 51.2 | 55.1 | |
| └ Share capital | 22.4 | 22.4 | 22.4 | 22.4 | 22.4 | 22.4 | 22.4 | 22.1 | |
| Borrowings | 13.2 | 20.7 | 25.1 | 25.7 | 21.5 | 19.6 | 20.5 | 21.8 | |
| └ Current | 5.4 | 13.3 | 18.2 | 19.0 | 12.4 | 11.0 | 12.6 | 13.0 | |
| └ Non-current | 7.8 | 7.4 | 7.0 | 6.7 | 9.2 | 8.7 | 7.9 | 8.7 | |
| Trade payables | 24.2 | 26.3 | 15.8 | 22.5 | 17.2 | 29.3 | 40.0 | 44.8 | |
| Current liabilities | 77.6 | 87.4 | 106.4 | 104.0 | 96.8 | 106.7 | 106.7 | 117.1 | |
| Total liabilities | 137.7 | 145.2 | 164.4 | 160.4 | 152.7 | 158.3 | 155.6 | 185.8 | |
| Net debt | (469.7) | (447.2) | (521.2) | (481.3) | (566.4) | (586.0) | (679.2) | (650.9) | |
| Debt / equity | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Current ratio | 9.31 | 8.43 | 7.61 | 7.76 | 9.09 | 8.75 | 9.78 | 8.91 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 140.4 | 42.1 | 141.4 | 43.0 | 142.5 | 64.7 | 156.8 | 77.2 | |
| └ Capex | (38.2) | (16.9) | (47.3) | (20.4) | (34.8) | (18.5) | (52.4) | (51.8) | |
| Free cash flow | 102.2 | 25.2 | 94.1 | 22.6 | 107.7 | 46.2 | 104.4 | 25.4 | |
| Investing cash flow | (298.2) | 14.8 | (64.6) | 3.3 | (89.1) | (30.7) | (74.1) | 44.3 | |
| Financing cash flow | (25.8) | (53.1) | (59.2) | (62.4) | (72.5) | (65.3) | (70.4) | (72.3) | |
| └ Dividends paid | (12.5) | (55.9) | (56.7) | (58.2) | (59.0) | (58.9) | (59.8) | (15.5) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (52.1) | |
| Net change in cash | (183.6) | 3.8 | 17.3 | (16.0) | (19.5) | (31.9) | 12.3 | 50.0 |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →ADVENZYMES at a glance
- ADVENZYMES closed at ₹290.45 on 20 Nov 2026, -1.96% on the day, -11.9% over one year, 30.7% below its 52-week high of ₹419.
- Delivery was 47.3% of traded quantity on 20 Nov 2026, the 42nd percentile of its own 2,541 sessions with a reading (20-session average 56.0%, 1-year average 54.2%).
- Market capitalisation is ₹3,203 crore at a trailing P/E of 18.7 (trailing EPS ₹15.5).
- Q2 FY27 results (consolidated, filed 31 Oct 2026): revenue ₹215 crore (+16.2% year on year), net profit ₹51 crore (+14.4%); the price moved +6.8% on the first session after.
- Promoters held 43.56% at 30 Sept 2026, up 0.32 percentage points on the previous filing.
- Q3 FY27 results are expected between 31 Jan 2027 and 11 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Biotechnology
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE